Key result
The phosphomimetic mutation S639D reduces actin-activated phosphate-release, which is the rate-limiting step in the steady-state actomyosin ATPase cycle.
Answers are grounded in this paper and cite their sources.
This study provides the first example of regulation of a myosin by covalent modification of loop-2, showing that Ser-639 phosphorylation reduces actin-activated phosphate-release.
Phosphorylation of Ser-639 in loop-2 of the catalytic motor domain of the heavy chain of Acanthamoeba castellanii myosin-2 and the phosphomimetic mutation S639D have been shown previously to down-regulate the actin-activated ATPase activity of both the full-length myosin and single-headed subfragment-1 (Liu, X., Lee, D. Y., Cai, S., Yu, S., Shu, S., Levine, R. L., and Korn, E. D. (2013) Proc. Natl. Acad. Sci. U.S.A. 110, E23–E32). In the present study we determined the kinetic constants for each step in the myosin and actomyosin ATPase cycles of recombinant wild-type S1 and S1-S639D. The kinetic parameter predominantly affected by the S639D mutation is the actin-activated release of inorganic phosphate from the acto myosin·ADP·P i complex, which is the rate-limiting step in the steady-state actomyosin ATPase cycle. As consequence of this change, the duty ratio of this conventional myosin decreases. We speculate on the effect of Ser-639 phosphorylation on the processive behavior of myosin-2 filaments. Background: Actin-activated ATPase activity of Acanthamoeba myosin-2 is inhibited by phosphorylation of Ser-639. Results: Kinetic constants for each step of the ATPase cycle were determined for wild-type myosin and the phosphomimetic mutant S639D. Conclusion: Ser-639 phosphorylation reduces actin-activated phosphate-release and hence the steady-state ATPase activity of the myosin. Significance: This is the first example of regulation of a myosin by covalent modification of loop-2.
No takes yet. Share an insight, caveat, or question.
Heissler et al. (2013) studied this question. Phosphomimetic mutation S639D vs. Recombinant wild-type S1 was evaluated on Kinetic constants for each step in the myosin and actomyosin ATPase cycles. The phosphomimetic mutation S639D reduces actin-activated phosphate-release, which is the rate-limiting step in the steady-state actomyosin ATPase cycle.
Synapse has enriched 10 related papers. Consider them for comparative context: